Navigation Links
Syncria (Type 2 Diabetes) - Analysis and Forecasts to 2020
Date:10/19/2011

>5 Evolution of Anti-Diabetic Treatments 18

6 Medications 19

6.1 Insulin 19

6.2 Oral Medications 19

6.2.1 Sulfonylureas (SUR) 19

6.2.2 Biguanides (BGDs) 19

6.2.3 Alpha-Glucosidase Inhibitors (AGI) 21

6.2.4 Meglitinides 21

6.2.5 Thiazolidinediones (TZDs) 22

6.2.6 Dipeptidyl Peptidase IV (DPP- 4) Inhibitors 23

6.2.7 Oral Combination Therapy 23

6.3 Other Injectionable Medications 24

6.3.1 Pramlintide 24

6.3.2 Exenatide 24

6.4 Market Share as per Classes in Type 2 Diabetes 24

7 Syncria 25

7.1 Introduction 25

7.2 Mechanism of Action 25

7.3 Clinical Studies 25

7.4 Factors Affecting Sales of Syncria 26

7.4.1 Once Weekly Dosage 26

7.4.2 Competition from Januvia 26

7.4.3 Approval of Bydureon 26

7.5 Drug Evaluation 27

7.5.1 Drug Risk Benefit Score 27

7.5.2 Intensity of Competition 27

7.6 Sales Forecasts 28

7.6.1 Target Patient Pool for Syncria 28

7.6.2 Dosing 28

7.6.3 Market Penetration 28

7.6.4 Annual Cost of Syncria 28

7.6.5 Sales Projections of Syncria 29

8 Diabetes Market: Appendix 38

8.1 Market Definitions 38

8.2 List of Abbreviations 38

8.3 Research Methodology 38

8.3.1 Coverage 39

8.3.2 Secondary Research 39

8.3.3 Forecasting 39

8.3.4 Net Penetration of Drug 40

8.3.5 Net Annual Dosing 40

8.3.6 Annual Cost of Therapy 40

8.3.7 Primary Research 40

8.3.8 Expert Panels 40

8.4 Drug Sales Estimates Model 41

8.5 Contact Us 41

8.6 Disclaimer 41

8.7 Sources 41

1.1 List of Tables

Table 1: Diabetes, World, Prevalence Estimates for the age group 20-79 years (million), 2000-2030 5

Table 2: Diabetes, Top 10 Countries, by Prevalence (million), 2010 and 2030 7

Table 3: Diabetes, Top 10 Countries, Highest Health Expenditures ($bn
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Study Shows GSKs Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
2. FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
3. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
6. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
7. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
8. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
9. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
10. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
11. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014   Decision Resources Group finds ... anemic chronic kidney disease non-dialysis (CKD-ND) patients are ... medication. In addition, one-year persistency is similar between ... Other key findings from the report entitled ... Erythropoiesis Stimulating Agents in Late Stage Chronic Kidney ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
(Date:9/30/2014)... DIEGO , Sept. 30, 2014   ... developing a minimally invasive real-time 3D Cardiac Chamber Imaging ... that cause and / or sustain complex cardiac arrhythmias, ... $26.2M financing to continue developing its imaging/mapping system as ... The financing will allow Acutus Medical to complete work ...
Breaking Medicine Technology:Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3
... Water Street Healthcare Partners , a strategic private equity ... it has acquired MarketLab, Inc.  Water Street,s ... specialty healthcare distribution sector.  The acquisition expands Water Street,s ... life sciences, medical devices and services to 13. ...
... -- Dehaier Medical Systems Ltd. (NASDAQ: ... in the development, assembly, marketing and sale of medical ... that it was granted three new patents by State ... ("SIPO"). The patent awards were related to the design ...
Cached Medicine Technology:Water Street Healthcare Partners Acquires MarketLab, Inc. 2Water Street Healthcare Partners Acquires MarketLab, Inc. 3Dehaier Strengthens Intellectual Property Portfolio 2Dehaier Strengthens Intellectual Property Portfolio 3
(Date:9/30/2014)... is the leading cause of cancer death in women, ... many medical professionals encourage women to get mammograms, even ... minority of suspicious mammograms actually leads to a cancer ... for women and their familiesnot to mention the time, ... biopsies. , Recently, a different type of test, ...
(Date:9/30/2014)... September 30, 2014 Keystone Symposia will convene ... first in its 2014-15 Global Health Series on ... Sheraton Seattle Hotel immediately following the conclusion of ... four-day conference is part of the Keystone Symposia Global ... Foundation, which has also funded travel awards for 36 ...
(Date:9/30/2014)... 30, 2014 A new study ... studied the impact of stress on metabolism after eating a ... fries from a fast food restaurant, about 930 calories and ... for 20 minutes every hour for 7 hours, conducting the ... women who had experienced a stressful event in their lives ...
(Date:9/30/2014)... September 30, 2014 Integrated Medicine ... is opening another new medical specialty practice through a ... Cardiology will be located within the company’s Shrewsbury ... and Dr. Isaac Tawfik of American Heart Center, P.C., ... new practice will offer Integrated Medicine Alliance patients top ...
(Date:9/30/2014)... by UC Irvine immunologists reveals new information about how ... process that determines how the body,s ability to fight ... Nature Immunology , neurology professor Dr. Michael Demetriou, postdoctoral ... describe a critical mechanism underlying how T cells are ... T cell is a type of blood cell called ...
Breaking Medicine News(10 mins):Health News:'Virtual breast' could improve cancer detection 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UCI study uncovers important process for immune system development 2
... combat death, heart attack and repeat procedures .,A recent ... of drug-coated stents on patients.// ,The study ... arteries who were treated with drug-eluting stents. An additional ... metal stents. ,Results of the one-year study ...
... studies have shown about 20 percent to 30 percent ... //either as bullies or as those attacked by bullies. ... they both bully others and are victims of bullies. ... than their peers who aren’t involved in bullying. However, ...
... study finds even flying in business class can put ... during long flights.// ,The link between blood ... during World War II, when doctors noticed a rise ... deck chairs in London air raid shelters. The association ...
... believe they’ve found a simple new test to detect ... ,In a report published in this week’s ... analysis of a person’s urine., ,Kidney cancer accounts ... cases were identified in the United States in 2003. ...
... and dieticians have been found effective in lowering total ... work only when these health professionals are able to ... program in which patients received their medications from their ... on factors aimed at improving their cardiovascular health. The ...
... procedure using less energy than the standard electrocautery may ... ,During a tonsillectomy using the electrocautery method, ... to control bleeding during the procedure. The microdissection needle ... which means less trauma to surrounding tissue., ,Researchers ...
Cached Medicine News:
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo...
... determines osmolality at room temperature with the ... get are cryoscopic artifacts due to high ... interfere with freezing point determinations. The superbly ... Vapro osmometer has a much broader range ...
Rapid assay, results in 1 hours,Range 20-800 ng/mL; sensitivity 2.5 ng/mL,Can be used for animal sera; requires extraction protocol and steroid free serum...
... IMMULITE 2000 assays ... with the IMMULITE 2000, ... access immunoassay analyzer. IMMULITE ... through centralization, and a ...
Medicine Products: